… revenue and profitability.The company significantly has increased its employee base recently to support growth. As an influx of CROs enter the Chinese market, the firm may have to offer higher compensation to attract qualified employees. Competition in China …
By Morningstar : By Lauren Migliore Contract research organizations dramatically cut costs and development time for drugmakers ..... increasing portion of their drug development work to CROs . We estimate that 35% of research and development …
Contract research organizations dramatically ..... development work to CROs . We estimate ..... activities to contract research organizations to improve ..... benefit from CROs ' specialization ..... for other CROs in the industry …
… as a way to win share in a crowded market.Vanda's practice of in-licensing compounds and using contract research organizations to conduct trials helps keep capital requirements and development risks low.The Novartis partnership …
… and flexibility offered by CROs to dramatically increase outsourcing ..... capacity underutilization at CROs and prompted concerns about ..... expense of smaller competitors. Contract research organizations ( CROs ) are able to dramatically …
… savings, and flexibility offered by CROs to dramatically increase outsourcing ..... long run. The value proposition of contract research organizations lies in their ability to dramatically ..... research and development activities to CROs , especially as major pharmaceutical …
… contract-based business, INC's need to successfully compete against larger and better-financed contract research organizations ( CROs ), and the need to quickly and effectively integrate the operations of Kendle. We believe INC's …
… outsource their research and development activities to contract research organizations to improve the efficiency and speed of testing, lower staffing and operating costs, and benefit from CROs ' specialization and expertise. Charles River estimates …
… drugmakers' increasing utilization of contract research organizations for clinical trial work. In addition ..... trial costs and development time, CROs allow drugmakers to shift to a variable ..... efficiency, and flexibility offered by CROs to more than outweigh big pharma …
… of-pocket burden. Further, the firm's fledgling central labs business has been hurt along with contract research organizations as pharmaceutical companies dialed down research and development spending in the economic downturn …